FDA Inspection
Bioreliance CorporationBioreliance Corporation – FDA Inspection, Jul 3, 2012
Record Details
This FDA Inspection record concerns Bioreliance Corporation, with an inspection on July 3, 2012, issued by the Center for Veterinary Medicine, covering veterinary.
- Company
- Bioreliance Corporation
- Inspection Date
- July 3, 2012
- Product Type
- Veterinary
View Company Profile
ID · ac18aec4-5a61-4f2e-82e2-135e1f2afee8
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 789270
- FDA center
- Animal Drugs & Feeds
- Project area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
FDA Citations
4- 21 CFR 211.160(a)Deviations from laboratory control requirements
- 21 CFR 211.160(a)Following/documenting laboratory controls
- 21 CFR 211.68(b)input/output verification
- 21 CFR 211.194(a)(4)Data secured in course of each test
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Bioreliance Corporation
11| Date | Classification | Office | Project area |
|---|---|---|---|
| January 29, 2026 | VAI | Baltimore District Office | Bioresearch Monitoring: Human Drugs |
| November 22, 2024 | VAI | Baltimore District Office | Vaccine, Allergenic, and Live Biotherapeutic Products |
| August 4, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 8, 2019 | Not classified | Baltimore District Office | |
| July 13, 2018 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
Other documents for Bioreliance Corporation
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.